Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Journal of Pharmacokinetics and Biopharmaceutics|April 1, 1982
Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppressionR D Toothaker, P G WellingAntimicrobial Agents and Chemotherapy|October 1, 1984
Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardiiR D Toothaker, G W ElmerJournal - Association of Official Analytical Chemists|January 1, 1985
Analytical methods for determining ascorbic acid in biological samples, food products, and pharmaceuticalsL A Pachla, D L Reynolds, P T KissingerJournal of Pharmaceutical Sciences|October 1, 1986
Robotic analysis of 3,7-dimethoxy-4-phenyl-N-1H-tetrazol-5-yl-4H-furo [3,2-b]indole-2-carboxamide in human plasmaE L Johnson, L A Pachla, D L ReynoldsJournal of Pharmaceutical Sciences|August 1, 1982
An in vitro model for the study of antibacterial dosage regimen designR D Toothaker, P G Welling, W A CraigInfection|January 1, 1984
Experimental meningitis in the rat: Haemophilus influenzaeA L Smith, M D Greenfield, R D ToothakerJournal of Pharmaceutical Sciences|October 1, 1982
Effect of dose size on the pharmacokinetics of oral hydrocortisone suspensionR D Toothaker, W A Craig, P G WellingClinical Chemistry|September 1, 1975
Colorimetric, enzymatic, and liquid-chromatographic methods for serum uric acid comparedW D Slaunwhite, L A Pachla, D C Wenke, et al.Journal of Clinical Pharmacology|January 1, 1993
Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacinP M Misiak, M A Eldon, R D Toothaker, et al.Antimicrobial Agents and Chemotherapy|November 1, 1987
Correction for bacterial loss in in vitro dilution modelsC A White, R D Toothaker, A L Smith, et al.Pageof 7